1251.2000 3.00 (0.24%)
NSE May 30, 2025 15:31 PM
Volume: 3.2M
 

1251.20
0.24%
ICICI Securities Limited
Dr. Reddy’s Laboratories’ (DRL) Q2FY25 performance, adjusted for acquisition-related expenses (INR 561mn) and impairment charge of gNuvaring (INR 924mn), was ahead of our expectations
Dr. Reddy's Laboratories Ltd. is trading above its 150 day SMA of 1225.4
More from Dr. Reddy's Laboratories Ltd.
Recommended